HiFiBiO Therapeutics' Series B Round

HiFiBiO Therapeutics raised a round of funding on May 16, 2018.

HiFiBiO Therapeutics is a multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with its single-cell profi…

Articles about HiFiBiO Therapeutics' Series B Round: